A new role for the HTLV-1 p8 protein: Increasing intercellular conduits and viral cell-to-cell transmission

Viruses

Volumn 3, Issue 3, 2011, Pages 254-259

  Malbec, Marine ^a   Roesch, Ferdinand ^a   Schwartz, Olivier ^a  

^a CNRS   (France)

Author keywords

Cell to cell transfer; Cellular conduits; HIV 1; HTLV 1; Nef; P12; P8; Virological synapses

Indexed keywords

CELL PROTEIN; NEF PROTEIN; PROTEIN P12; PROTEIN P8; UNCLASSIFIED DRUG;

ANTIGEN RECOGNITION; ARTICLE; CELL INVASION; COCULTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1; NONHUMAN; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; SYNAPSE; VIRUS CELL INTERACTION; VIRUS INFECTIVITY; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS TRANSMISSION;

CELL LINE; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 1;

EID: 79953104280     PISSN: None     EISSN: 19994915     Source Type: Journal    
DOI: 10.3390/v3030254     Document Type: Article

References (23)

1. Van Prooyen, N.; Gold, H.; Andresen, V.; Schwartz, O.; Jones, K.; Ruscetti, F.; Lockett, S.; Gudla, P.; Venzon, D.; Franchini, G. Human T-cell leukemia virus type 1 p8 protein increases cellular conduits and virus transmission. Proc. Natl. Acad. Sci. U. S. A. 2010, 107, 20738-20743.
2. Igakura, T.; Stinchcombe, J.C.; Goon, P.K.; Taylor, G.P.; Weber, J.N.; Griffiths, G.M.; Tanaka, Y.; Osame, M.; Bangham, C.R. Spread of HTLV-I between lymphocytes by virus-induced polarization of the cytoskeleton. Science 2003, 299, 1713-1716.
3. Bangham, C.R. The immune control and cell-to-cell spread of human T-lymphotropic virus type 1. J. Gen. Virol. 2003, 84, 3177-3189.
4. Fukumoto, R.; Andresen, V.; Bialuk, I.; Cecchinato, V.; Walser, J.C.; Valeri, V.W.; Nauroth, J.M.; Gessain, A.; Nicot, C.; Franchini, G. In vivo genetic mutations define predominant functions of the human T-cell leukemia/lymphoma virus p12I protein. Blood 2009, 113, 3726-3734.
5. Taylor, J.M.; Brown, M.; Nejmeddine, M.; Kim, K.J.; Ratner, L.; Lairmore, M.; Nicot, C. Novel role for interleukin-2 receptor-Jak signaling in retrovirus transmission. J. Virol. 2009, 83, 11467-11476.
6. Pais-Correia, A.M.; Sachse, M.; Guadagnini, S.; Robbiati, V.; Lasserre, R.; Gessain, A.; Gout, O.; Alcover, A.; Thoulouze, M.I. Biofilm-like extracellular viral assemblies mediate HTLV-1 cell-to-cell transmission at virological synapses. Nat. Med. 2010, 16, 83-89.
7. Miller, M.D.; Warmerdam, M.T.; Gaston, I.; Greene, W.C.; Feinberg, M.B. The human immunodeficiency virus-1 nef gene product: a positive factor for viral infection and replication in primary lymphocytes and macrophages. J. Exp. Med. 1994, 179, 101-113.
8. Albrecht, B.; Collins, N.D.; Burniston, M.T.; Nisbet, J.W.; Ratner, L.; Green, P.L.; Lairmore, M.D. Human T-lymphotropic virus type 1 open reading frame I p12(I) is required for efficient viral infectivity in primary lymphocytes. J. Virol. 2000, 74, 9828-9835.
9. Kestler, H.W., 3rd; Ringler, D.J.; Mori, K.; Panicali, D.L.; Sehgal, P.K.; Daniel, M.D.; Desrosiers, R.C. Importance of the nef gene for maintenance of high virus loads and for development of AIDS. Cell 1991, 65, 651-662.
10. Valeri, V.W.; Hryniewicz, A.; Andresen, V.; Jones, K.; Fenizia, C.; Bialuk, I.; Chung, H.K.; Fukumoto, R.; Parks, R.W.; Ferrari, M.G.; Nicot, C.; Cecchinato, V.; Ruscetti, F.; Franchini, G. Requirement of the human T-cell leukemia virus p12 and p30 products for infectivity of human dendritic cells and macaques but not rabbits. Blood 2010, 116, 3809-3817.
11. Thoulouze, M.I.; Sol-Foulon, N.; Blanchet, F.; Dautry-Varsat, A.; Schwartz, O.; Alcover, A. Human immunodeficiency virus type-1 infection impairs the formation of the immunological synapse. Immunity 2006, 24, 547-561.
12. Fukumoto, R.; Dundr, M.; Nicot, C.; Adams, A.; Valeri, V.W.; Samelson, L.E.; Franchini, G. Inhibition of T-cell receptor signal transduction and viral expression by the linker for activation of T cells-interacting p12(I) protein of human T-cell leukemia/lymphoma virus type 1. J. Virol. 2007, 81, 9088-9099.
13. Schwartz, O.; Marechal, V.; Le Gall, S.; Lemonnier, F.; Heard, J.M. Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nat. Med. 1996, 2, 338-342.
14. Johnson, J.M.; Nicot, C.; Fullen, J.; Ciminale, V.; Casareto, L.; Mulloy, J.C.; Jacobson, S.; Franchini, G. Free major histocompatibility complex class I heavy chain is preferentially targeted for degradation by human T-cell leukemia/lymphotropic virus type 1 p12(I) protein. J. Virol. 2001, 75, 6086-6094.
15. Schibeci, S.D.; Clegg, A.O.; Biti, R.A.; Sagawa, K.; Stewart, G.J.; Williamson, P. HIV-Nef enhances interleukin-2 production and phosphatidylinositol 3-kinase activity in a human T cell line. AIDS 2000, 14, 1701-1707.
16. Ding, W.; Kim, S.J.; Nair, A.M.; Michael, B.; Boris-Lawrie, K.; Tripp, A.; Feuer, G.; Lairmore, M.D. Human T-cell lymphotropic virus type 1 p12I enhances interleukin-2 production during T-cell activation. J. Virol. 2003, 77, 11027-11039.
17. Haller, C.; Tibroni, N.; Rudolph, J.M.; Grosse, R.; Fackler, O.T. Nef does not inhibit F-actin remodelling and HIV-1 cell-cell transmission at the T lymphocyte virological synapse. Eur. J. Cell Biol. 2010.
18. Nobile, C.; Rudnicka, D.; Hasan, M.; Aulner, N.; Porrot, F.; Machu, C.; Renaud, O.; Prevost, M.-C.; Hivroz, C.; Schwartz, O.; Sol-Foulon, N. HIV-1 Nef Inhibits Ruffles, Induces Filopodia, and Modulates Migration of Infected Lymphocytes. J. Virol. 2010, 84, 2282-2293.
19. Schwartz, O.; Riviere, Y.; Heard, J.M.; Danos, O. Reduced cell surface expression of processed human immunodeficiency virus type 1 envelope glycoprotein in the presence of Nef. J. Virol. 1993, 67, 3274-3280.
20. Banerjee, P.; Feuer, G.; Barker, E. Human T-cell leukemia virus type 1 (HTLV-1) p12I down-modulates ICAM-1 and -2 and reduces adherence of natural killer cells, thereby protecting HTLV-1-infected primary CD4+ T cells from autologous natural killer cell-mediated cytotoxicity despite the reduction of major histocompatibility complex class I molecules on infected cells. J. Virol. 2007, 81, 9707-9717.
21. Kim, S.J.; Nair, A.M.; Fernandez, S.; Mathes, L.; Lairmore, M.D. Enhancement of LFA-1-mediated T cell adhesion by human T lymphotropic virus type 1 p12I1. J. Immunol. 2006, 176, 5463-5470.
22. Xu, W.; Santini, P.A.; Sullivan, J.S.; He, B.; Shan, M.; Ball, S.C.; Dyer, W.B.; Ketas, T.J.; Chadburn, A.; Cohen-Gould, L.; Knowles, D.M.; Chiu, A.; Sanders, R.W.; Chen, K.; Cerutti, A. HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits. Nat. Immunol. 2009, 10, 1008-1017.
23. Sowinski, S.; Jolly, C.; Berninghausen, O.; Purbhoo, M.A.; Chauveau, A.; Kohler, K.; Oddos, S.; Eissmann, P.; Brodsky, F.M.; Hopkins, C.; Onfelt, B.; Sattentau, Q.; Davis, D.M. Membrane nanotubes physically connect T cells over long distances presenting a novel route for HIV-1 transmission. Nat. Cell Biol. 2008, 10, 211-219.